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Abstract 
 
Background: Diabetic foot ulcers are susceptible to infection and non-medicated dressings 
are ineffective because they have no antimicrobial activity. This study aimed to develop 
antimicrobial films to deliver ciprofloxacin for treating bacterial infection. 
Results/Methodology: Ciprofloxacin loaded calcium alginate films were characterized for 
porosity, swelling, equilibrium water content, water absorption, water vapour transmission, 
evaporative water loss, moisture content, mechanical strength, adhesion, infrared 
spectroscopy, scanning electron microscopy, X-ray diffraction, drug release, cytotoxicity and 
antimicrobial activity against E. coli, S. aureus and P. aeruginosa. Films were transparent, 
flexible, uniform, with ideal moisture handling, maximum drug release within 90 min, killing 
bacteria within 24 h and highly biocompatible with human keratinocyte cells.  
Conclusions: The results confirmed successful design of biocompatible dressings effective 
against Gram positive and Gram negative bacteria.  
 
Keywords: Antibacterial activity, calcium alginate, chronic wounds, ciprofloxacin, diabetic foot 
ulcers, glycerol, moisture handling, solvent cast film, wound healing. 
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Introduction 
 
 The prevalence of chronic wounds, including diabetic foot, leg and pressure ulcers has 
increased significantly around the world. It is predicted that in 20 years from 2005 to 2025, 
the number of patients with chronic wounds will increase from 60.4 million to 63.8 million 
[1]. Foot ulcerations are very common in diabetic patients and it is estimated that more than 
60, 000 of these patients are likely to have foot ulcers at any given time in England alone [2]. 
The annual cost of wound care for wound dressings and other materials in the United 
Kingdom (UK) alone was £420 million in 2014 and will increase to £461 million from 2014 
to 2019 [3]. It is reported that £972 million to £1.13 billion was spent for foot ulceration and 
amputation in diabetes in 2014-15, which is equivalent to 0.72-0.83% of the National Health 
Service budget in England [2,4].  
According to statistics for England and Wales in 2014-16, about 45.6% and 42.8% of 
foot ulcer episodes in patients with type 1 and type 2 diabetes respectively, had bacterial 
infection [5]. Various clinical studies have reported that the most predominant bacterial 
species in diabetic foot ulcers (DFUs) are Staphylococcus aureus, Pseudomonas aeruginosa 
and Escherichia coli [6-9]. A clinical study reported that S. aureus and P. aeruginosa were 
isolated from diabetic foot infections in about 38.4% and 17.5% of cases respectively [7], 
whilst isolates of E. coli was found in about 14.6% of cases [9]. In another study, 84 patients 
with infected DFUs were investigated and it was found that the prevalence of S. aureus was 
the most common and approximately 50% of the isolates were resistant to methicillin [10]. 
Therefore, the demand for developing antimicrobial wound dressings is increasing. 
Medicated film dressings can also reduce the cost burden as a result of lower production costs 
[11,12] in comparison with other advanced alternatives such as tissue engineered substitutes. 
Further, antimicrobial dressings applied locally to the wound site avoid unwanted effects; 
interfering with the healing process and inducing resistance to the loaded active ingredient 
[13].   
Current commercial film dressings are semipermeable, thin, flexible sheets of clear 
polyurethane incorporating an adhesive coating on one side to allow adherence to the skin. 
They are highly elastic, conform to any contour of the body and are suitable as primary or 
secondary dressings. Their transparency allows useful visualization of the wound bed during 
healing without the need for removal, therefore reducing the chances of traumatising the 
wound and causing pain. They are permeable to gases (water vapour, oxygen and carbon 
dioxide) but impermeable to bacteria and liquid water (exudates) due to semi-occlusive 
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nature. This means that oxygen is allowed into the wound to promote healing while, water 
vapour and carbon dioxide produced can easily escape [14] and this helps to achieve lower 
overall infection rates than traditional dressings such as gauze and cotton wool. It was 
reported that films promote faster wound healing, decrease pain, cause less scaring, allow 
visual wound assessment and facilitate patient mobility and hygiene [15].  
In recent years, novel film dressings made of natural, synthetic or semi synthetic 
polymers such as alginate, chitosan, collagen, gelatine, polyvinyl alcohol, polyethylene oxide 
have been reported [16,17]. Calcium alginate (CA) extracted from brown seaweed, consists 
of homo polymeric regions of mannuronic acid (M) and guluronic acid (G). Dressings 
obtained from alginates form an ordered structure in solution and produce strong gels on the 
wound surface upon exudate absorption [17,18]. Therefore, they permit permeation of water 
vapour, oxygen and metabolites which can facilitate the healing of ischemic DFUs while 
protecting the wound bed against debris and microbial penetration. Furthermore, CA has 
hemostatic and antimicrobial properties, making the dressings effective in healing wounds 
[19,20].  
Ciprofloxacin (CIP), is a fluoroquinolone derivative, which is highly effective against 
both Gram positive and Gram negative bacteria due to its low minimum inhibitory 
concentration (MIC) [21-23]. The MIC for CIP is reported for E. coli, S. aureus and P. 
aeruginosa as 0.015 µg/ml, 0.5 µg/ml and 0.25 µg/ml respectively [24]. The chemical 
structure of CIP is 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-
carboxylic acid with the 6-fluoro and cyclopropyl substituent responsible for antibacterial 
activity. In addition, the 7-piperazino group has been found to be responsible for inhibiting 
Pseudomonas spp. CIP acts by inhibiting topoisomerase II (DNA gyrase) and topoisomerase 
IV, which are responsible for ATP-dependent negative supercoiling of bacterial DNA 
replication, transcription, repair and recombination [25].  
 There are many alginate based commercial dressings on the market but CIP loaded 
alginate based dressings are currently not available whilst recent studies lack data showing 
effective bacterial inhibitions and low cytotoxicity. Therefore, in this study, CIP loaded CA 
based films prepared by solvent casting technique were characterized for different functional 
properties expected for effective wound dressings. To the best of our knowledge, there has 
been no research study undertaken on alginate-glycerol-ciprofloxacin composites in the form 
of film dressings to potentially treat infected DFUs. A related study was previously reported, 
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where CIP was loaded in composite sodium alginate/gelatine films, [26] whilst other studies 
did not report on films [27, 28]. Though two studies reported complete eradication of E. coli 
and P. aeruginosa, [27, 29], no studies of CIP loaded dressings have shown complete killing 
of S. aureus. The hypothesis is that, low but effective antibacterial doses of CIP will reduce 
local cytotoxicity and enhance cell viability (biocompatibility) when applied over long 
periods as happens in chronic wounds such as DFUs. Finally, this is the first study testing the 
biocompatibility of CIP loaded film dressings using human keratinocyte skin cells. . .  
Materials and methods 
 
Formulation development and optimisation 
 
Preliminary formulation of blank (BLK) films 
Different 1% w/v gels were prepared by dissolving CA (Sigma Aldrich, Gillingham, 
UK) in different concentrations (0.005-0.028 M) of sodium carbonate solution (Fisher 
Scientific, Loughborough, UK). Furthermore, different amounts (9.1, 20.0, 33.3, 42.8 and 
50.0%) of glycerol (GLY) (Fisher Scientific, Loughborough, UK) based on the total polymer 
weight (w/w) were added to the gels after which 20g of each gel was poured into Petri dishes 
with diameter of 86 mm and dried (30ºC) for18 h to obtain films. The films were visually 
examined identify any physical defects. 
 
Preparation of drug loaded (DL) films 
 Based on preliminary observation of the plasticised films prepared above, drug was 
loaded into the optimized film containing 33.3% (w/w) GLY. Initially CIP (Sigma Aldrich, 
Gillingham, UK) was dissolved in 0.014 M sodium carbonate solution from an initial stock 
solution (250 μg/ml) of the drug. To obtain the DL films, GLY was dissolved in sodium 
carbonate solution by stirring at 50ºC for 10 min and then drug solution (to achieve drug 
concentrations of 0.005, 0.010 and 0.025% w/v) was mixed with the plasticised gel under 
continuous stirring. After that, CA powder was added in tiny amounts to avoid lump 
formation with continuous stirring for 3 h. Finally, 20 g of the gels were poured into Petri 
dishes and dried in a 30ºC oven for 18 h to obtain the films, which were wrapped with 
parafilm and kept in a desiccator until required.    
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Fluid handling properties 
Porosity 
The porosity of the films was measured using a previously reported ethanol displacement 
method [30-32]. Briefly, the samples were immersed in 10 ml of ethanol (Fisher Scientific, 
Loughborough, UK) over a period of 3 h to achieve saturation level. The samples were 
initially weighed before immersing into the solvent and reweighed after being saturated. The 
total pore volume was initially determined from the thickness and diameter of the films and 
subsequently used to calculate film porosity (n = 3) according equation 1: 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) =
𝑊𝑖−𝑊0
ρeth 𝑉0
 𝑥 100        (1) 
Where, W1 is the saturated weight and W0 is the dry weight of the samples. V0 is the total pore 
volume calculated from its geometrical dimensions and ρeth is the density of ethanol (0.789 
g/cm3). 
Water absorption, equilibrium water content and swelling index 
The water absorption (Aw),  equilibrium water content (EWC) and swelling index (Is) 
of all the films  were measured using aqueous based simulated wound fluid (SWF) at pH of 
7.5, prepared from  bovine serum albumin (BSA)=2% (w/w), calcium chloride-0.02 M, 
sodium chloride-0.4 M, tris (hydroxymethyl) aminomethane-0.08 M (all from Fisher 
Scientific, Loughborough, UK). To determine the Aw, samples were weighed and kept in 10 
ml of SWF over a 24 h period at a temperature of 37ºC. After 24 h, samples were carefully 
wiped using tissue paper to remove excess SWF and reweighed and the Aw calculated using 
equation 2 below. Each measurement was performed in triplicate (n = 3) 
𝐴𝑤(%) =
𝑊𝑠−𝑊𝑖
𝑊𝑖
𝑥 100         (2) 
Where Ws is the swollen weight and Wi is the initial weight before immersion into SWF. 
 
To determine the EWC, the same procedure was followed as for Aw, however, the 
EWC (n = 3) was calculated using equation 3 below. 
𝐸𝑊𝐶(%) =
𝑊𝑠−𝑊𝑖
𝑊𝑠
𝑥 100         (3) 
For swelling, the weighed samples were dipped into 10 ml of SWF (at ambient 
temperature) and changes in weight of swollen films recorded at 15 min intervals up to 1 h 
and subsequently every 60 min until 5 h. The swelling index (Is) was calculated (n = 3) from 
equation 4 below.  
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𝐼𝑠 (%) =
𝑊𝑠𝑡−𝑊𝑖
𝑊𝑑
 𝑥 100                                (4) 
Where Wi is the dry weight of samples before hydration and Wst is the swollen weight of 
samples at different hydration times.  
Further, the effect of drug concentration on Aw, EWC and Is was determined.  
 
Water vapour transmission rate 
With the help of epoxy glue, the films were used to cover fully the mouth of 25 ml 
Falcon tubes with diameter of 15 mm. The tubes were previously filled with of 15 ml water 
which allowed an air gap of 8 mm between the surface of the water and the films. The whole 
assembly was then put into an oven (37°C) with air circulation at for 24 h. The WVTR (n = 
3) was calculated using equation 5: 
WVTR =
Wb−Waf
A
x106 g/m2 day-1        (5) 
 Where A = area of the mouth of the Falcon tube (πr2), Wb and Waf are the weights of the 
whole setup before and after placing into oven respectively.   
 
Evaporative water loss 
The films were placed in SWF and incubated in an oven at 37°C for 24 h. After that 
films were removed and dried at 37°C for a further 24 h with sample weight measured at 
specified time intervals. Evaporative water loss (n = 3) was calculated using equation 6 
below: 
𝑊𝑎𝑡𝑒𝑟 𝑙𝑜𝑠𝑠 (%) =  
𝑊𝑡
𝑊𝑖
 𝑥 100      (6) 
Where Wt is the weight of film after time ‘t’ and Wi represents the initial weight after 24 h 
immersion in SWF. 
 
Moisture content 
The residual moisture content was analysed using thermogravimetric analysis (TGA) 
by employing a Q5000-IR TGA instrument (TA Instruments, Crawley, UK). The film sample 
(1.0 - 1.5mg) was loaded and analysed by heating from 25ºC - 300ºC at 10ºC/min under 
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constant stream of nitrogen gas flowing a 50 mL/min. The residual moisture content was 
determined at 100ºC by calculating the percentage weight change at that temperature with the 
help of the TA Instruments Universal Analysis 2000 software. 
 
Physico-chemical Characterisation 
Texture analysis 
Mechanical properties  
The tensile properties (tensile strength, Young’s modulus and percent elongation) of 
the films were analysed by stretching on a TA HD Texture analyser (Stable Microsystem 
Ltd., Surrey, UK) in tensile mode equipped with a load maximum load of 5kg and a  Texture 
Exponent 32 software program for data plotting and display. The films with dimensions of 80 
mm total length, 30 mm gauge length and width of 3.5 mm were cut into dumb-bell shapes 
and their average thickness entered into the software programme. The films were then 
stretched between two tensile grips using the following settings: test speed (0.10 mm/sec), 
trigger force (0.05 N), and pre-test speed (1.00 mm/sec) and post-test speed (10.00 mm/sec) 
at respectively. Initially, the test was carried out on the BLK films containing different 
percentages of plasticizer (1% CA-9.1% GLY, 1% CA-20.0% GLY, 1% CA-33.3% GLY, 
1% CA-42.8% GLY and 1% CA-50.0% GLY) to define the formulation with optimum 
mechanical properties to use for drug loading [33]. Subsequently, DL films were tested to 
determine the effect of drug loading. Three main tensile properties (tensile strength, Young’s 
modulus and elongation at break) were calculated (n = 3) from equations 7, 8 and 9 [17].  
Tensile strength (N mm2⁄ ) =
Force at break (N)
Initial cross sectional area  (mm2)
           (7) 
 
Young′s modulus (MPa) =
Slope
Film thickness (mm)x cross−head speed (mm s⁄ ) 
      (8) 
 
Elongation at break (%) =
Increase in length (mm)at break
Initial film length (mm)
 x 100              (9) 
 
 
  
8 
 
In-vitro adhesion  
 The adhesive test was performed using a texture analyser (TA.HD. plus) (Stable 
Microsystem Ltd., Surrey, UK) to evaluate the adhesive properties, that is; stickiness (peak 
adhesive force - PAF), total work of adhesion (WOA) and cohesiveness of the films. Before 
the experiment, 500 µl of SWF containing 2% w/v bovine serum albumin (Fisher Scientific, 
Loughborough, UK), representing protein rich exudate, was spread on the surface of set 
gelatine (6.67% w/w) gel layer to mimic a chronic wound surface and the gel was placed on 
the stationary platform of the texture analyser. Samples were attached to a cylindrical 
stainless steel probe (35 mm diameter) with the help of double sided adhesive tape and the 
probe set to approach the model wound surface. Based on previous report [33], measurements 
were obtained using the following settings: pre-test and test speeds of 0.5 mm/s respectively; 
post-test speed of 1 mm/s; auto trigger force of 0.05 N; applied force at 1 N; contact time of 
60 s and return distance of 10 mm. The adhesive properties were calculated using the Texture 
Exponent 32 software. The results were obtained from the analysis of three different parts of 
the films and mean ± SD calculated for each adhesive parameter. 
 
Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy and 
Infrared (IR) mapping  
A FTIR spectrophotometer (Two Perkin Elmer, USA) was used in combination with a 
crystal diamond universal attenuated total reflectance (UATR) to characterize pure CIP and 
pure CA as well as the BLK and DL films. Samples were placed to cover the crystal and the 
metal tip turned around in order to allow intimate contact of the samples with the crystal. 
Spectra were recorded in transmission mode between 650 and 4000 cm-1 at a resolution of 4 
cm-1 (4 scans per spectrum). A background spectrum was taken before analysing the samples 
to calibrate the instrument. IR mapping of the surface of the films was performed using a 
Nicolet™ iN™ 10 MX Infrared Imaging Microscope (Thermo Fisher Scientific, USA) 
equipped with OMNIC™ Picta™ to investigate the chemical distribution of materials within 
the polymeric films. Liquid nitrogen was poured into the system to analyse the samples with 
cooled detector in the measurement range 4000-650 cm-1 and spectra were collected in 
reflection mode with 3s collection time. For each spectrum, 70 spots and 16 scans were 
combined. Four characteristic peaks for the films (CA-BLK and CA-DL) were selected as 
spectral markers of pure CA. 
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Scanning electron microscopy (SEM) 
 The surface morphology of the films was observed by a Hitachi SU 8030 scanning 
electron microscope (Hitachi High-Technologies, Germany) with an operating voltage of 10 
kV. The samples were fixed onto aluminium stubs and chromium coated with a sputter coater 
for 5 min. The SEM micrographs were taken at working distances between 8.1 mm to 9.0 
mm at x6000 magnification with the help of i-scan 2000 software. The images were captured 
at three different areas of the films to evaluate the consistency of the microstructures.  
 
In-vitro drug dissolution  
Drug content uniformity (DCU) and the total drug content (TDC) of the films were 
investigated before drug dissolution to ensure uniform drug distribution within the film 
matrix. The DCU was determined by cutting the films into circular strips (6 mm diameter) 
from three different locations and accurately weighed. The films were initially hydrated in 10 
ml of purified water at 37 ºC and then left overnight with continuous stirring to allow 
complete dissolution. To determine TDC, the whole film was hydrated in 50 ml of purified 
water. The quantity of drug in solution was determined by HPLC after filtration.  
For the drug dissolution, a diffusion cell designed within our laboratories at the 
University of Greenwich was employed. The diffusion cell has wire mesh on the top where 
the samples are placed and SWF (pH 7.5) without BSA was used as a dissolution medium in 
the receptor compartment. About 30 ml of dissolution medium was poured into the cell with 
the liquid medium just touching the lower surface of the films to ensure adequate hydration. 
A magnetic bead was previously placed into the cell and the entire system was then inserted 
into a constant temperature water bath offset to 37ºC and continuously stirred at 600 rpm 
throughout. Aliquots (1 ml) were sampled from the dissolution medium at different time 
points and replaced with the same volume of SWF to maintain a constant volume. The 
experiments of each sample (1% CA-0.005% CIP, 1% CA-0.010% CIP and 1% CA-0.025% 
CIP) were performed in triplicate and the mean cumulative percentage drug release from the 
films was calculated using a standard calibration curve. 
 
HPLC analysis 
HPLC was performed using the Agilent 1200 series HPLC (Agilent Technologies, 
UK) with a quaternary pump, an auto sampler and Chemstation® software program for 
controlling the instrument and analysing data. . A C18 analytical column (YMC-Pack ODS-
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AQ AQ-303-5, 250x4.6 mm I.D, S-5 μm, 120A, NO.042512322) was used as a stationary 
phase. The mobile phase consisted of a two solvent isocratic system in which 2% acetic acid 
and acetonitrile were used in the ratio of 70: 30 at a flow rate of 1 ml/min. The UV detector 
wavelength for CIP was set at 280 nm and 20 μl volumes were injected during each run. The 
stock solution of CIP was prepared in 2% acetic acid at a concentration of 500 µg/ml. The 
working solutions of CIP were prepared by diluting the required volumes of the stock 
solution with mobile phase to obtain concentrations ranging from 1 to 100 µg/ml in triplicate 
for the calibration curve (189.35x, R2 = 0.9993). The reproducible retention time for CIP was 
4.89 min.     
 
Drug release kinetics 
 The mechanism of drug release was investigated by measuring the kinetics of CIP 
release from the polymeric films and fitting the release data to four kinetic equations; 
Higuchi, Korsmeyer-Peppas, zero order and first order equations [34]. Korsmeyer-Peppas 
equation (10) was used to understand the mechanism of drug release. 
ln (
𝑄𝑡
𝑄∞
) = ln 𝑘 + 𝑛 ln  𝑡         (10) 
Qt and Q∞ are the absolute cumulative amounts of drug released at time (t) and infinite time 
respectively, k is a constant related to the structural and geometrical characteristic of the 
films and n is the release exponent.  
 
Biological characterisation 
Methylthiazolyldiphenyl-tetrazolium (MTT) bromide- (cell viability) assay 
In vitro cytotoxicity of CIP loaded films was evaluated on adult human primary 
epidermal keratinocytes (PEK) (PCS-200-011, ATCC) (LGC Standards, Middlesex, UK). 
Films were cut into 6 mm circular discs and sterilized overnight using UV light. The samples 
were then immersed in 1.5 ml of dermal cell basal medium (PCS-200-030, ATCC) 
supplemented with keratinocytes growth kit (PCS-200-040, ATCC) (LGC Standards, 
Middlesex, UK) for 24 h in a Heracell 150i CO2 incubator, Thermo Scientific) at 37ºC. The 
liquid samples were filtered through a 0.2 μm filter and the filtrate collected. In this study, 
cytotoxicity test was performed by indirect contact of the samples with the cells. The PEK 
cells were separately cultured in 96-well tissue-culture polystyrene plates at a density of 1000 
cells/well in the complete growth medium for 5 h to allow cell attachment. After that, the 
media were replaced with extraction media and the cells were re-incubated for up to 72 h. 
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The viability of the cells cultured with each of the sample extraction media was finally 
determined using the ATCC recommended protocol by adding 10 µl of MTT reagent 
(Thermo Fisher Scientific, Paisley, UK) to each well including those containing only the 
medium (blank) and incubated at 37ºC in 5% (v/ v) CO2 for 4 h. Subsequently, the media was 
removed and purple formazan crystals formed were solubilized with 100 µl of DMSO (Fisher 
Scientific, Loughborough, UK). After incubating at 37ºC in 5% (v/ v) CO2 for another 30 
min, the absorbance of each well at 492 nm was recorded with the help of a microtiter plate 
reader (Multiskan FC, Thermo Scientific) that had a SkanIt Multiskan FC 3.1 software 
(Thermo scientific). The cell viability (%) was reported relative to the negative control wells 
not exposed to the dressings and blank well containing only fresh cell culture medium. Cells 
treated with only Triton-X-100 (0.01% w/v) were also tested as positive control. Each 
experiment was carried out in triplicates (n = 3) and repeated three times. The percentage cell 
viability was calculated as shown in  equation 11 below. 
 
Cell viability (%) =  
At−Ab
Ac−Ab
∗ 100       (11) 
Where At, Ab and Ac are the absorbance of tested samples, blank (medium only) and 
negative control (untreated cells) respectively.  
 
Antibacterial study 
 Antimicrobial activity of the films containing different amounts (0.005, 0.010 
and 0.025% w/v) of CIP were evaluated using turbidimetric, Kirby-Bauer disc diffusion and 
time kill assays. Briefly, bacterial inocula of E. coli (ATCC 25922), S. aureus (ATCC 29213) 
and P. aeruginosa (ATCC 27853) (from the University of Greenwich microbiology 
laboratories) were prepared from fresh colonies on Mueller Hinton (MH) agar # 3 technical 
(Fisher Scientific, Loughborough, UK). After overnight incubation, the bacterial suspensions 
were adjusted to 0.5 McFarland standard representing ~108 CFU/ml. In the turbidimetric 
method, 0.1 ml of bacteria suspensions were added to each tube containing 9.9 ml of MH 
broth (Sigma Aldrich, Gillingham, UK) to achieve bacterial concentration of 106 CFU/ml 
representing a high microbial load in infected DFUs [35, 36]. The DL films (6 mm diameter) 
and filter discs containing 5 µg of pure CIP as positive controls were then transferred into the 
tubes. Tubes containing only bacteria were used as negative controls. The tubes were 
incubated at 37 ºC, with stirring (180 rpm) and aliquots taken at 1.5, 3, 6, 12 and 24 h and 
absorbance recorded at 625 nm. In addition, 0.1 ml aliquots were plated directly or after serial 
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dilution to count the number of viable bacterial colonies and only plates having 30 to 300 
colonies were accepted for determining number of colony forming units/ml (CFU/ml) [37]. 
For each organism, three replicates (n = 3) were carried out.    
The antimicrobial activity of the dressings was further evaluated by Kirby-Bauer disk 
diffusion method. A sterile swab was immersed into the tube containing bacterial suspension 
(106 CFU/ml) and streaked over MH agar plates to obtain uniform growth. Circular films (6 
mm diameter) were placed on the colonised agar plates and incubated for 24 h (at a 
temperature of 37ºC), and then zone of inhibition (ZOI) in mm was subsequently determined 
with the help of a digital Vernier calliper.  
 
Statistical analysis 
Statistical analysis was undertaking by performing t-test and ANOVA) with Microsoft 
Excel for comparing quantitative data between BLK and DL films, and p values below 0.05 
considered as significant. 
 
Results and discussion 
Formulation development and optimisation 
Calcium alginate (CA) is water insoluble but readily dissolves in sodium carbonate 
solution [18]. The chemistry behind this is that CA forms a gel via ion exchange method, 
with the divalent calcium ions present in β-D mannuronic acid (M block) of CA exchanging 
with the monovalent sodium ions of the surrounding medium thus forming arranged 
structures known as an egg box model [38]. The gels were prepared by vortex hydration with 
heat which helps to quickly hydrate the undissolved polymer, thus preventing lump formation 
[39]. Heat also helps to reduce the viscosity of the gels, resulting in ease of pouring into the 
casting containers and also to remove air bubbles entrapped during stirring. Due to gel 
uniformity (homogeneity), viscosity, absence of lump formation and ease of pouring, 1% 
w/w polymer gels were selected and further investigated to improve the transparency and 
flexibility of the resulting films. The films obtained from gels at concentrations greater than 
1% w/w were very hard, brittle, deformed, opaque and inflexible, whereas, films obtained 
from 0.5% w/w gel were too thin and weak to handle and easily torn. This shows that higher 
amount of polymer made the films hard and leads to compact structure [40]. However, films 
obtained from CA- 0.5% w/w gels were more transparent compared to other films obtained 
from gels with higher amounts of polymer, but with visible calcium carbonate precipitation 
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(see XRD discussion below).. Films obtained from 1% w/w gel were less brittle with lower 
precipitation of calcium carbonate compared to all other films, however, they were less 
transparent (translucent) as shown in Figure S1 of the supplementary information.  
Further investigation was carried out by dissolving CA in different concentrations of 
sodium carbonate solution to reduce calcium carbonate precipitation on the film surface. 
Figure S2 shows that films obtained from CA gels prepared using 0.005-0.011 M sodium 
carbonate solution were fragile, brittle, deformed, cracked and even more calcium carbonate 
precipitation. This could be due to the fact that there was not enough sodium ions present. 
Therefore, the gels were less viscous and evaporated quickly during drying. On the other 
hand, CA dissolved in 0.028 M sodium carbonate solution resulted in the least brittle film 
but, precipitation of calcium carbonate was high. CA dissolved in 0.014 M sodium carbonate 
gave uniform, homogenous and adequate viscous gels, permitting ease of pouring into the 
Petri dish and resulting in the least precipitation of calcium carbonate among all the films. 
This could be due to the fact that the ratio between CA and sodium carbonate was optimum 
for ionic cross-linking, leaving less calcium carbonate residues.  
All the unplasticized films did not show the ideal mechanical properties expected of 
films i.e. durable, soft, flexible, pliable and elastic [33]. To achieve that, the films obtained by 
dissolving CA in 0.014 M sodium carbonate, were plasticized with different amounts of GLY 
and digital photographic images are illustrated in Figure S3. Addition of GLY made them 
more flexible and also improved their transparency. The films plasticized with more than 
33.3 % w/w GLY were difficult to remove from the Petri dish owing to strong adhesion as 
the films became sticky due to the migration of GLY toward the surface, through a leaching 
phenomenon [38]. However, all plasticized films were transparent which will allow the 
inspection of the wound bed without the need to remove the dressing. It was observed that 
films containing GLY at 33.3% w/w (based on total dry weight) were more flexible and 
tougher than any other plasticized films. The flexibility of the films is important to ensure 
ease of application to the wound area whilst toughness see tensile data below is important to 
allow handling as well as resisting the external pressure exerted during body movements 
around the wounded area. Therefore, the plasticized film containing 33.3% w/w GLY (CA-
BLK) was selected for drug loading.  
The common problem of DL films is the precipitation of drug by recrystallization 
during film formation as water evaporated from the gel matrix, especially at high drug 
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loading [41]. The DL films showed ideal physical appearance as no recrystallized drug was 
visible to the eye (Figure S4). 
 
Porosity 
Films are semipermeable in nature and generally appear as continuous sheets of polymer with 
limited, As shown in Table 1, the unplasticized blank film showed the highest porosity of 56 
± 1% amongst all the formulated films. Addition of GLY decreased porosity because it 
coated the surface of the films and therefore reduced pore size. The porosity was significantly 
(p = 0.0002) reduced when the films were plasticized with 33.3% GLY or above because 
increased GLY could increase the viscosity of the gels and subsequently yielded more non-
porous sheets of polymer. However, incorporation of drug into polymeric matrix (CA film) 
increased the porosity significantly (p = 0.009) when compared to the CA-BLK film (CA-
33.3% GLY). CIP reduced the intermolecular polymer chain interaction and increased void 
spaces between the polymer chains resulting in higher porosity than the BLK films. 
Moreover, the porosity was slightly increased with increasing amount of drug into the films. 
 
Water absorption (Aw) and equilibrium water content (EWC) 
The Aw and EWC are two functional properties that impact upon absorption of 
exudates at reasonably rapid rates. EWC and Aw of the films gradually decreased with 
increasing GLY content as shown in Table 1. The unplasticized films showed the highest 
EWC and Aw of 79 ± 1 % and 380 ± 12 % respectively whereas films plasticized with 50% 
w/w GLY showed the lowest EWC and Aw of 66 ± 1% and 193 ± 5% respectively. This 
could be attributed to the porosity of the dressings where addition of GLY decreased their 
porosity (see Table 1) and therefore, decreased the EWC and Aw. The DL films showed a 
higher EWC and Aw compared to CA-BLK films. The values of EWC and Aw of CA-BLK 
film increased from 74 ± 1% to 77 ± 1% and 282 ± 8% to 328 ± 25 respectively; after loading 
drug. This is also due to increase in porosity of the DL films which enabled ingress and 
retention of more fluid within the swollen film matrix.  
 
Water vapour transmission rate 
DL films exhibited  higher WVTR values (Table 1) ranging from 3257 ± 172 to 3877 ± 196 
g/m2day-1 than the films without drug (2687 – 3682). This is because; addition of drug 
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increases the intermolecular chain mobility, resulting in increased porosity which allows 
higher diffusion of water molecules through the films matrix. High WVTR will prevent 
excess accumulation of wound exudates and subsequently prevent maceration of surrounding 
healthy skin. The WVTR values of DL films are ideal considering the amount of exudate 
produced by patients with chronic leg ulcers per day (5 g/10 cm2 ̴ 5000 g/ m2) [42]. 
Therefore, the DL films will absorb about 65-77% fluid from full-thickness chronic wound 
bed whilst also maintaining a moist environment to facilitate wound healing. 
 
Swelling index 
The swelling behaviour of the films was evaluated in SWF (pH 7.4) and the effect of 
GLY and drug was also investigated (Figure 1). The unplasticized film (1% CA-0.0% GLY) 
showed the highest swelling index ranging from 453 ± 35% to 434 ± 22% over 60 min, while 
film plasticized with 50% GLY showed the lowest swelling index ranging between 206 ± 2% 
and 197 ± 3%.  
The addition of GLY reduced swelling capacity because of the reduction in porosity 
as well as its humectant properties [43]. As porosity decreases, water ingress into the matrix 
also decreases resulting in reduced initial hydration and subsequent swelling. Moreover, GLY 
is already rich in moisture, so it does not allow absorption of high amounts of moisture, 
however, the plasticized film dressings can provide moisture in dry wounds to avoid wound 
desiccation.  The film containing 33.3% GLY showed swelling capacity value ranging from 
299 ± 7% to 284 ± 8 % over 60 min. After loading drug into this film, the swelling capacity 
did not change in a significant way. However, the plasticised (1% CA-33.3% GLY) film 
containing 0.005% drug showed the lowest swelling capacity amongst the DL films, with 
values ranging from 231 ± 17% to 229 ± 7% over 60 min. This could be due to the fact that 
the film containing 0.005% CIP was more rigid (also confirmed by texture analysis, Figure 
2a) than other DL films which resulted in lower porosity (Table 1) and therefore lower rate 
of water intake. It can also be observed that all films maintained steady swelling after 15 min. 
 
Evaporative water loss (EWL)  
 The EWL indicates moisture loss behaviour of the dressings when exposed to air. All 
the films exhibited water loss of about 50% within half an hour, indicating that generally, the 
dressings can lose water quickly when they come into contact with air. After 1.5 h the water 
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loss from unplasticized, plasticized and 0.010% DL films was not significant (p = 0.78) and 
retained 17-20% of water after 24 h (Figure S5 of supplementary information,). However, 
films containing 0.005 % and 0.025% CIP acquired steady water content within 5 h and 
retained 13-11% water after 24 h.  The fast water loss and low amount of water remaining 
within the matrix indicates that the films will be highly effective in highly exuding chronic 
wounds such as DFUs as it will enable the dressings to imbibe enough exudates from the 
wound bed by an active upward diffusion process to avoid excess accumulation of exudate 
underneath the dressing.   
 
Moisture content 
Thermogravimetric analysis detected the residual water content of the formulated films. The 
uplasticized film showed residual moisture content of about 5 ± 1% which increased up to 8 ± 
0% after addition of GLY. The increase is due to the hydrophilicity and strong humectant 
properties of GLY. Since GLY is highly hydrophilic, the content of GLY in the films resulted 
in higher amounts of bound water and therefore enhancing residual moisture content [44]. 
After loading CIP, the residual moisture content was further increased to about 11 ± 0% 
because of increase in porosity which enabled it to absorb more moisture.  It could also be 
observed that the incorporation of drug increased hydrophilicity of the polymeric matrix 
resulting in higher amounts of bound water and therefore increased residual moisture content. 
However, high enough residual water within the dressings can keep the wound and 
surrounding normal skin in an ideal state of hydration, implying that the dressings are 
expected to perform effectively when compressed during application [45].  
 
Texture analysis  
The DL plasticized films, BLK plasticized films and BLK unplasticised films were tested by 
texture analyser for tensile strength (brittleness), elasticity (% elongation at break) and elastic 
modulus (rigidity) and adhesion properties to understand the effects of drug loading and 
plasticizer on the polymeric matrix. 
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Mechanical (tensile) properties of films 
The ideal film dressing should be flexible, durable, soft, elastic, pliable and stress 
resistant against different parts of the body during application. Texture analysis was used to 
investigate whether the formulated film dressings possessed these ideal mechanical 
properties. The clear correlation between GLY content and the mechanical properties of films 
were observed with unplasticized films being too brittle (Figure S1: CA-1.0% w/w) and 
failed during texture analysis. The tensile strength of the plasticized films increased with 
addition of GLY up to 33.3%. The values ranged from 5 ± 1 N/mm2 to 15 ± 2 N/mm2 as 
shown in Figure 2a. However, addition of higher amounts of GLY (42.8 and 50.0 %) 
resulted in a lowering of tensile strength (9 ± 1 N/mm2 and 7 ± 1 N/mm2). The decrease in 
tensile strength at higher GLY content might be due to leaching phenomena with significant 
reduction of intermolecular and intramolecular bonding in the CA network. 
Further, investigations were undertaken by measuring Young’s (elastic) modulus and 
elongation at break to optimise GLY content for DL films. Young’s modulus was estimated 
from the slope of the initial linear portion of stress-strain curve. Figure 2a shows that the 
Young’s modulus increases gradually with increasing GLY and after certain GLY content it 
decreased as was the case with tensile strength values. The maximum Young’s modulus (78 ± 
9 MPa) was achieved at a GLY concentration of 33.3% w/w. Figure 2a also illustrates the 
effect of GLY on the films elongation which increased with increasing GLY content. This is 
because addition of GLY increased the number of –OH groups resulting in weak hydrogen 
bonding within CA. The intermolecular force decreased resulting in increased mobility 
caused by enlarged spaces between polymeric chains and subsequent increase in percentage 
elongation at break. A sharp rise in elongation can be observed in Figure 2a when the 
concentration of GLY was above 33.3% w/w in the gel. The significant (p = 0.002) increase 
in elongation corresponded to a decrease in Young’s modulus. 
The above mechanical properties, confirmed the selection of films containing 33.3% 
w/w of GLY for drug loading. As shown in Figure 2a, the differences in tensile strength and 
percentage elongation of films containing 0.005% CIP were insignificant (p = 0.84 & p = 
0.07) when compared to BLK film. However, Young’s modulus was significantly (p= 0.01) 
decreased after loading drug. Films loaded with more than 0.005% CIP were highly brittle as 
evidenced by having the lowest elongation (4 ± 2%). None of the DL films and CA-BLK 
showed ideal values (30-50%) of elasticity [46]. However, the Young’s modulus and tensile 
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strength values showed the film containing 0.005% CIP was not too brittle and this was 
confirmed during handling of this film. Moreover, all the values of mechanical properties 
were decreased with increasing concentration of drug that indicated low drug loading 
capacity of the CA based films, usually attributed to the reduced physical volume available 
for drug distribution. The mechanical tensile behaviour of CA films depend on the source and 
extraction treatment, and ratio of guluronic and mannuronic acid of the polymer [47]. The 
mechanical properties of films can be improved by combining the polymer with either natural 
or synthetic polymers as reported by Boateng and co-workers [33,39,48]. 
 
In-vitro adhesion studies 
As shown in Figure 2b, the stickiness of the films increased with increasing GLY 
content in the presence of SWF containing 2% w/w BSA. This could be explained by the fact 
that GLY enhances the hydrogen bonding between the polymeric chain and model wound 
surface and therefore increases adhesion properties. Furthermore, GLY acts as a humectant 
that promotes initial hydration in the presence of SWF which consequently imparts the 
increased stickiness. The stickiness of DL dressings also did not change when compared to 
the BLK film (1% CA-33.3% GLY). Figure 2b also shows the WOA and cohesiveness of the 
films. Cohesiveness means ability to resist the detachment from model wound surface, 
whereas WOA represents the total energy required to separate the probe from the wound 
surface. The cohesiveness of the films containing 0.005 and 0.010% CIP was significantly (p 
= 0.001) increased compared to all other formulations. The value increased from 1.07 ± 0.24 
mm to 7.02 ± 0.24 mm indicating that the films containing 0.005 and 0.001% CIP will adhere 
onto the wound surface better. Films loaded with 0.025% CIP showed low cohesiveness of 
about 2.05 ± 0.43 mm which can be attributed to poor mechanical properties in terms of 
Young’s modulus, elongation and tensile strength. The WOA slightly increased with 
increasing drug concentration. However, the values for 0.005, 0.010 and 0.025% CIP loaded 
films (0.94 ± 0.29, 1.44 ± 0.35 and 1.40 ± 0.56 N.mm respectively) did not exceed the value 
(1.47 ± 0.31 N.mm) for BLK film and there was no significant difference (p= 0.6) in WOA 
between BLK and DL films. 
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Fourier transform infrared spectroscopy and infrared mapping 
The FTIR spectra of different starting materials (CIP, GLY and CA) and DL dressings 
are shown in Figure 3. Some of the characteristic peaks from CIP such as aryl fluoride (at 
1050 cm-1), carbonyl group (at 1450 cm-1) and quinolones (at 1650 cm-1) were invisible in the 
spectra of DL dressings. This might be due to the fact that the relatively low amounts of CIP 
incorporated were suppressed by the higher amounts of polymer and plasticizer that 
prevented them from being visible in the spectra. This also suggests the possible molecular 
dispersion of drug into the polymeric matrix. Pure CA showed the broad peak of OH 
stretching at 3204 cm-1 and this peak became broader (band between 3045 and 3600 cm-1) 
and less intense (confirmed by IR imaging, Table S1) after loading drug. This could be 
explained by the fact that incorporation of drug into polymeric gel promoted interaction of 
fluorine, carbonyl and amine (-NH) of CIP with hydrogen atom of CA resulting in shorter 
distance between the drug molecules and OH group of CA and therefore, broadened the peak 
with lower intensity. Lower intensity might also be related to decreased crystallinity of the 
DL films confirmed by XRD and SEM. A band appeared at 874 cm-1 for β-C1-H deformation 
vibration and at 947 cm-1 for C-O stretching vibration of uronic acid and C-C-H and C-O-H 
deformation. The peak at 1025 cm-1 was for the C-O-C for antisymmetric stretching vibration 
of pyranosyl ring. This peak was stronger in the pure polymer than the DL films as red 
domains appeared more in pure CA and gradually changed to blue in DL films. Further, 
another two peaks can be seen at 1411 and 1591 cm-1 for the symmetric and asymmetric 
stretching of carboxylate ion (-COO-) respectively. Most of the peaks of CA-BLK (1% CA-
33.3% GLY) and DL loaded dressings were similar to the pure polymer but different in 
intensity and also confirmed by IR imaging (Table S1). Different intensities of the bands 
indicate the uniform distribution of the polymer and the drug, and homogeneity of films 
[49,50]. The overlay plot (data not shown) of the spectral profiles of the films from different 
collection points (10 x 7) also confirmed uniform chemical distribution of the materials.  
 
Scanning electron microscopy 
From Figure 4 it can be observed that the surface of the films was generally not 
smooth possibly due to calcium carbonate precipitation in the formulations as the films dried 
and this was also confirmed by XRD (Figure S6). However, the plasticized films appeared 
smoother than the unplasticized film (CA-0.0% GLY). This indicates that addition of GLY 
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largely improves the homogeneity of the CA films by reducing or masking calcium carbonate 
precipitation with decrease in the crystallinity on the surface as the amount of GLY 
increased. This is because the hydroxyl groups in GLY penetrated into the polymeric matrix 
and formed hydrogen bonds with hydroxyl groups of CA thus creating large spaces between 
the polymeric chains, resulting in reduced surface crystallinity [47]. However, presence of 
calcium carbonate did not affect the homogeneous distribution of the drug throughout the 
films confirmed by drug content uniformity test (Table S2). Further, it has been reported that 
calcium carbonate is good for bone regeneration [51] and also possessing antibacterial 
activity [52]. Therefore, presence of some amount of residual calcium carbonate will be 
expected to play a partial role in the closure (healing) of DFUs.  
The DL films showed (Figure 4) a smoother surface morphology compared to CA-
BLK film.. This be due to the fact that, after adding CIP, the number of hydroxyl groups 
increased, thus enhancing interaction between the CIP molecules, and the polymer, and 
therefore promoting intermolecular hydrogen bonding. This helped to increase the spaces 
between the crystal lattice and engulfed the residual calcium carbonate and thereby decreased 
the overall crystallinity of the DL films. 
 
In-vitro drug dissolution studies  
The drug loading efficiency determined for films containing 0.005, 0.010 and 0.025% 
CIP was 65.81 ± 3.98%, 60.99 ± 2.01% and 55.01 ± 4.27% respectively, which appeared 
relatively low. This could be explained by the fact that the drying process during film 
formation results in a dense and very thin product resulting in precipitation of excess drug on 
the surface of the films some of which can be lost through scraping and contact during 
handling [53]. Moreover, it also reveals that higher amounts of drug originally added into the 
dressings resulted in decreasing loading efficiency into the dressing matrix. The drug content 
uniformity was also investigated to check the homogeneous distribution of the drug all over 
the dressings. The HPLC analysis from three different locations of the dressings confirmed 
that there was no statistically significant difference (Table S2) in drug content. In addition, 
the distribution of drug was also be confirmed by antibacterial study of testing ZOI see below 
as well as IR mapping (Table S1). 
5 µm 5 µm 
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The drug release profiles closely matched the swelling (Figure 1) of the films. A 
quick hydration of the dressings was observed within 15 min and within this time more than 
50% drug was released. This means films containing 0.005% and 0.010% CIP can reach 
MBC (99.9% inhibition) to eradicate E. coli and P. aeruginosa within that time. In the case 
of films containing 0.025% CIP is expected to achieve MBC for killing all three organisms 
(E. coli, P. aeruginosa and S. aureus) within 5 min. The films exhibited maximum drug 
release within 45 min about 90.50 ± 3.93%, 91.18 ± 7.44% and 100. 41 ± 11.15% 
respectively (Figure 5). This indicates that the release of CIP from the film dressings could 
potentially reduce microbial load very quickly, which is important in highly infected chronic 
wounds such as DFUs where the bacteria load needs to be significantly reduced to allow 
wound healing to progress beyond the inflammatory phase.  
 
Drug release kinetics 
 CIP loaded films showed diverse release profiles, evaluated by model dependant 
equations such as Higuchi, Korsmeyer-Peppas, zero order and first order [34]. All data 
obtained from those mathematical equations are summarized in Table S3. It can be observed 
from Table S3 that release of CIP from the films followed first order release mechanism in 
which release rate depends on the concentration of drug. Figure 5 also supports this kinetic 
mechanism of drug release where the highest amount of drug (0.025% w/v) loaded film 
released maximum drug within 45 min.  For a better understanding of drug release 
mechanism, the diffusion exponent (n) values from the Korsmeyer-Peppas equation, were 
calculated and fell within the range of 0.54-0.59. This suggested CIP was released from the 
films by anomalous transport, which implies that the release of CIP from the hydrated 
polymer combined gel erosion and diffusion of the drug through the swollen gel.   
        
MTT (cell viability) assay 
Cytotoxicity test is vital when chemicals and devices such as drug loaded dressings, 
are likely to come into contact with the wounded skin as well as normal skin. The CIP loaded 
film dressings were applied to human primary epidermal keratinocyte (PEK) cell lines, 
representing wounded skin. MTT assay revealed that the polymer (CA) used in this study was 
non-toxic to human keratinocyte cells. The BLK film showed about 88.3 ± 1.0% cell viability 
over 72 h (Figure 6). All DL dressings showed more than 80% cell viability over 72 h which 
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are acceptable according to International Organization for Standardization (DIN EN ISO 
10993-5). Time dependent cell viability of PEK was also observed when treated with DL 
films. Triton-X-100 (positive control) killed all cells compared to untreated cells (negative 
control) after 72 h of exposure. Additionally, the keratinocytes were observed 
microscopically before and after treatment with the samples. In the case of DL dressings, the 
viable cells appeared as polygonal structures adhered to the well plates (image not shown). 
Very few dead non adherent cells were observed after treating with the dressings, whereas 
most of the cells were floating when treated with Triton-X-100. There was no reduction of 
adherent cell numbers in untreated cells. These observations further confirm the non-toxic 
nature of the drug loaded dressings compared to the known toxic Triton-X-100. 
 
Antibacterial Study 
The absorbance readings measured showed significant difference (p = 0.001) between 
E. coli, S. aureus and P. aeruginosa incubated with BLK and CIP loaded films (Figure S7. a-
c). Clear bacterial suspensions also showed that the released antibiotic was effective in 
eradication of the bacterial load (Figure S7 (a-c), whilst BLK films showed no antibacterial 
effects, confirming the ZOI assay below (Figure S8). The optical density (OD) values of the 
negative control containing only bacteria and the -BLK films gradually increased over time. 
However, the DL films showed values below 0.25 throughout the period of incubation. The 
low OD values of DL dressings was due to decreased turbidity because of bacterial 
eradication, and was confirmed by the time kill assay. Figure 7 illustrates the rate of bacterial 
(106 CFU/ml representing chronic wounds) eradication when treated with DL films. Pure CIP 
(positive control) and film containing 0.025% CIP (w/v) completely killed E. coli after 1.5 
and 3 h respectively. Complete eradication of E. coli by films containing 0.005% and 0.010% 
CIP (w/v) was observed at 24 h. S. aureus is the most common infection causative bacteria 
present in DFUs, however, all viable cells of S. aureus were killed by the DL films within 24 
h. The complete eradication of P. aeruginosa was also observed after 24 h of treatment. The 
tube containing only bacteria (negative control) showed an increase in cell count confirming 
the importance of rapid eradication of bacterial cells to prevent infection progression. It was 
also noticed that all DL films exhibited maximum bactericidal effect (99.9% reduction of 
bacterial cells) within 1.5 h which correlates well with the in vitro drug release data.  
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Zone of inhibition (ZOI) of the positive control (pure CIP) were 37± 1, 28 ± 1 and 34 
± 1 against E. coli, S. aureus and P. aeruginosa respectively (Figure S8 and Table S4). 
According to reported standard guidelines, in disk diffusion technique, 5 μg CIP should have 
ZOI of 30-40, 22-30 and 25-33 mm against E. coli, S. aureus and P. aeruginosa respectively 
[54]. CIP loaded films showed ZOI of 34-38, 27-32 and 29-33 mm against E. coli, S. aureus 
and P. aeruginosa respectively (Table S4), therefore this experiment achieved this 
standardization. In addition, the average ZOI for E. coli, S. aureus and P. aeruginosa 
increased as the CIP content increased within the dressings. Clear ZOIs were observed 
(Figure S8) in DL films for both Gram-positive and Gram-negative bacteria, however, BLK 
films showed no ZOI against all the three bacteria tested,  which confirmed that the CA on its 
own did not possess any antibacterial activity.  
 
Conclusions 
 The films plasticised with 33.3% w/w GLY were soft, flexible, pliable and transperant 
and drug incorporation did not affect the transperency indicating uniform drug distribution 
without significant precipitation which was confirmed by SEM, XRD, FTIR, IR mapping and 
drug content uniformity studies. The dressings exhibited potential tensile and bio-adhesive 
properties required for easy application and to ensure adherence to the wound bed. The DL 
films showed higher Aw (328 ± 25) and EWC (77 ± 1) than the BLK films, influenced by 
their differences in porosity, however, their swelling index values were similar.  The high 
WVTR (maximum 3877 ± 196 g/m2day-1) and EWL (50% within half an hour) indicate that 
the films will remove exudates from the wound bed through the polymer swollen matrix into 
the surrounding environment rapidly. The films exhibited maximum drug release (> 90%) 
within 45 min which will provide enough drug concentration to reduce bacterial load before 
the next change of the dressing. Complete eradication of all causative bacteria were observed 
after 24 h which will be very effective to prevent infection progression in DFUs. The 
dressings showed more than 80% cell viability of PEK over 72 h which confirmed their 
safety for patients. Although CA antimicrobial film dressings exhibited promising 
characteristics for wound healing, in vivo wound healing study will need to be undertaken in 
the future to confirm its effectiveness. 
 
  
24 
 
Future Perspective 
In the next five to ten years, interest in advanced bioactive medicated dressings such as 
ciprofloxacin loaded alginate films, which take an active part in the wound healing process, 
will continue to grow. This will be driven by the need for more effective but affordable 
therapies that will shorten the treatment regime and reduce the chances of hospital acquired 
resistant bacterial infections, which are a common cause of amputations and mortality in 
DFU patients. Broad spectrum antibiotic loaded dressings comprising well established 
bioactive polymers such as alginate will probably compliment the silver based antibacterial 
dressings currently on the market to increase the chances of fully arresting the scourge of 
chronic ulcers caused by prolonged infection. 
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Executive Summary  
 Alginate film dressings were successfully prepared from CA by ion exchange method 
and transparent and flexible films were obtained by adding GLY as a plasticizer.  
 The formulated films showed ideal fluid handling properties in terms of Aw, EWC, 
swelling index, WVTR and EWL. 
 Uniform distribution of drug and polymer within the film matrix was confirmed by IR 
imaging and drug content uniformity test, indicating that the film can be cut to the 
desired size and will work effectively due to proper distribution of drug and polymer. 
 The quick release of CIP from the dressings can ensure rapid eradication of both 
Gram positive and Gram negative bacteria, to reduce deterioration of chronic DFUs 
and enhance healing times. 
 The most prevalent bacteria present in DFUs were completely killed within 24 h of 
treatment while testing in-vitro. 
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 The formulated film showed high biocompatibility with the human primary epidermal 
keratinocytes cells indicating that the films will safe for both healthy skin and newly 
formed tissue in the wounded area.     
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Table 1 The porosity, EWC, Aw, WVTR and moisture content, of different film formulations 
(n = 3 ± SD).  
Films Porosity 
(%) 
EWC (%) Aw (%) WVTR (g/m2day-1) Moisture 
content (%) 
1% CA-0.0% GLY 56 ± 1 79 ± 1 380 ± 12 3185 ± 739 5 ± 1 
1% CA-9.1% GLY 55 ± 5 79 ± 0 379 ± 6 3450 ± 417 8 ± 0 
1% CA-20.0% GLY 51 ± 3 75 ± 1 309 ± 17 2687 0± 226 7 ± 1 
1% CA-33.3% GLY 38 ± 4 74 ± 1 282 ± 8 2919 ± 224 8 ± 1 
1% CA-42.8% GLY 34 ± 4 70 ± 1 239 ± 6 3483 ± 9 8 ± 0 
1%CA-50.0% GLY 30 ± 2 66 ± 1 193 ± 5 3682 ± 215 8 ± 0 
1% CA-0.005% CIP 46 ± 6 74 ± 1 287 ± 7 3809 ± 48 11 ± 0 
1% CA-0.010% CIP 51 ± 1 77 ± 1 328 ± 25 3257 ± 172 11 ± 0 
1% CA-0.025% CIP 54 ± 2 75 ± 2 295 ± 30 3877 ± 196 10 ± 0 
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Figure 1 Swelling profiles of unplasticized, plasticized-BLK and plasticized-DL films 
(mean ± SD, n =3).  
 
 
 
0
100
200
300
400
500
0 15 30 45 60
S
w
el
li
n
g
 I
n
d
ex
 (
%
)
Time (min)
1% CA-0.0% GLY 1% CA -9.1 % GLY 1% CA-20.0% GLY
1% CA -33.3% GLY 1% CA-42.8% GLY 1% CA-50.0% GLY
1% CA-0.005% CIP 1% CA-0.010% CIP 1% CA-0.025% CIP
0
10
20
30
40
50
60
70
80
90
100
Tensile strength(N/mm2)
Young's modulus (MPa)
Elongation (%)
a 
33 
 
 
 
Figure 2 Texture analysis profiles showing (a) tensile and (b) adhesive results for BLK 
and DL films. 
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Figure 3  FTIR spectra of pure CIP, CA, GLY, CA-BLK and CA-DL films. 
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Figure 4 SEM images of unplasticized-BLK, plasticized-BLK and plasticized DL films 
captured at x6000 magnification. 
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Figure 5 Cumulative percentage drug release profiles of CIP loaded films showing rapid 
drug release over a 90 min period. 
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Figure 6 Cell viability of human primary epidermal keratinocytes after exposure to the 
extracts of BLK and CIP loaded films and Triton-X for 24, 48 and 72 h (mean ± SD, n = 9).  
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Figure 7 Rate of bacterial inhibitions after treating with CA film dressings against: (a) E. 
coli, (b) S. aureus and (c) P. aeruginosa. 
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